| Secondary |
| Cardiac Disorder |
28.0% |
| Hypertension |
18.0% |
| Cardiac Failure |
10.0% |
| Myocardial Ischaemia |
8.0% |
| Cardiovascular Disorder |
6.7% |
| Product Used For Unknown Indication |
4.7% |
| Gastritis |
3.3% |
| Myocardial Infarction |
3.3% |
| Atrial Fibrillation |
2.7% |
| Hypertensive Cardiomyopathy |
2.7% |
| Diabetes Mellitus |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Anticoagulant Therapy |
1.3% |
| Essential Hypertension |
1.3% |
| Hyperuricaemia |
1.3% |
| Ischaemic Cardiomyopathy |
1.3% |
| Urinary Tract Infection |
1.3% |
| Raynaud's Phenomenon |
0.7% |
| Thrombosis Prophylaxis |
0.7% |
| Type 2 Diabetes Mellitus |
0.7% |
|
| Dermatitis Exfoliative Generalised |
23.7% |
| Renal Failure Acute |
10.5% |
| Dermatitis Exfoliative |
7.9% |
| Nodal Arrhythmia |
7.9% |
| Syncope |
7.9% |
| Vision Blurred |
7.9% |
| Fall |
5.3% |
| Hyperkalaemia |
5.3% |
| Renal Failure Chronic |
5.3% |
| Asthenia |
2.6% |
| Blood Bicarbonate Decreased |
2.6% |
| Hip Fracture |
2.6% |
| Hyponatraemia |
2.6% |
| Hypotension |
2.6% |
| Rash Erythematous |
2.6% |
| Treatment Noncompliance |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.8% |
| Product Used For Unknown Indication |
23.0% |
| Cardiac Failure Chronic |
7.5% |
| Atrial Fibrillation |
6.1% |
| Sepsis |
4.8% |
| Hypertension |
4.4% |
| Cardiomyopathy |
3.2% |
| Hepatic Neoplasm Malignant |
3.2% |
| Cardiac Failure |
2.9% |
| Pulmonary Hypertension |
2.7% |
| Prophylaxis |
2.4% |
| Hepatic Cirrhosis |
2.0% |
| Thrombosis Prophylaxis |
1.9% |
| Bipolar I Disorder |
1.5% |
| Diabetes Mellitus |
1.5% |
| Hyperuricaemia |
1.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.4% |
| Atrial Flutter |
1.0% |
| Gastric Cancer |
1.0% |
| Hypocalcaemia |
1.0% |
|
| Renal Failure Acute |
11.5% |
| Erysipelas |
9.2% |
| Pulmonary Oedema |
6.9% |
| Jaundice |
5.7% |
| Subdural Haematoma |
5.7% |
| Syncope |
5.7% |
| Toxic Skin Eruption |
5.7% |
| Confusional State |
4.6% |
| Erythema |
4.6% |
| Multi-organ Failure |
4.6% |
| Oliguria |
4.6% |
| Palpitations |
4.6% |
| Vomiting |
4.6% |
| Bone Marrow Failure |
3.4% |
| Diarrhoea |
3.4% |
| Hepatic Function Abnormal |
3.4% |
| International Normalised Ratio Increased |
3.4% |
| Melaena |
3.4% |
| Agranulocytosis |
2.3% |
| Cardiac Arrest |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
33.3% |
| Atrial Fibrillation |
20.0% |
| Hypertension |
20.0% |
| Anticoagulant Therapy |
6.7% |
| Cardiac Failure |
6.7% |
| Diarrhoea |
6.7% |
| Intentional Drug Misuse |
6.7% |
|
| International Normalised Ratio Fluctuation |
25.0% |
| International Normalised Ratio Increased |
25.0% |
| Renal Failure Acute |
25.0% |
| Renal Impairment |
25.0% |
|
